Ex Vivo Activated Haploidentical Natural Killer Cell Therapy
体外激活单倍体相合自然杀伤细胞疗法
Report date: 2022/12/31 17:30:31
Base Information
Drug NameEx Vivo Activated Haploidentical Natural Killer Cell Therapy
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRoyan Institute
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A